Ferozsons Laboratories Limited profit surges 22%

September 23, 2025 (MLN):  Ferozsons Laboratories Limited (PSX: FEROZ) has shared its consolidated financial results for the year ended June 30, 2025, reporting a robust growth in both revenue and profit.

The company's profit after taxation surged by 22% to Rs921.71 million, compared to Rs755.4m in the previous fiscal year (FY24).

This impressive performance translated into a significant increase in earnings per share, which rose to Rs17.86 from Rs15.72 in FY24, an increase of 13.6%.

The company's net revenue saw an increase of 18.9% YoY, reaching Rs18.86bn in FY25 from Rs15.85bn in FY24.

Despite this, the cost of sales also increased by 15.6% YoY to Rs10.86bn, compared to Rs9.39bn last year. This led to a gross profit of Rs7.99bn, reflecting a healthy 23.7% growth from Rs6.46bn in FY24.

Operating expenses continued to climb, with administrative expenses rising by 6.7% to Rs901.83m and selling and distribution expenses surging by 30.8% to Rs4.95bn.

Other expenses increased by 8.6% to Rs267.46m. In a positive development, other income also grew by 11.4% to Rs254.94m.

As a result of the strong top-line growth and disciplined cost management, profit from operations increased by 17.5% to Rs2.13bn, up from Rs1.82bn in the last fiscal year.

The company also managed to reduce its finance costs by 14.6% to Rs574.28m, compared to Rs672.45m in FY24.

After accounting for finance costs, the profit before income tax, final, and minimum tax amounted to Rs1.56bn, marking a significant 36.4% jump from Rs1.14bn last year.

After accounting for minimum tax differential, the company's profit before income tax stood at Rs1.53bn, a 37.9% increase.

Despite a substantial 72.0% rise in income tax to Rs603.48m, Ferozsons Laboratories closed FY25 with a net profit of Rs921.71mi, solidifying its strong financial performance.

Copyright Mettis Link News